293 related articles for article (PubMed ID: 10447735)
1. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
[TBL] [Abstract][Full Text] [Related]
3. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
[TBL] [Abstract][Full Text] [Related]
5. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
[TBL] [Abstract][Full Text] [Related]
7. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
8. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
[TBL] [Abstract][Full Text] [Related]
9. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
[TBL] [Abstract][Full Text] [Related]
10. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4-deficient mice.
Pearlman E; Lass JH; Bardenstein DS; Diaconu E; Hazlett FE; Albright J; Higgins AW; Kazura JW
Exp Parasitol; 1996 Nov; 84(2):274-81. PubMed ID: 8932777
[TBL] [Abstract][Full Text] [Related]
11. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density.
Brattig NW; Lepping B; Timmann C; Büttner DW; Marfo Y; Hamelmann C; Horstmann RD
J Infect Dis; 2002 Apr; 185(8):1148-54. PubMed ID: 11930325
[TBL] [Abstract][Full Text] [Related]
12. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
[TBL] [Abstract][Full Text] [Related]
13. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen.
Plier DA; Awadzi K; Freedman DO
J Infect Dis; 1996 Aug; 174(2):380-6. PubMed ID: 8699070
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.
Doetze A; Satoguina J; Burchard G; Rau T; Löliger C; Fleischer B; Hoerauf A
Int Immunol; 2000 May; 12(5):623-30. PubMed ID: 10784608
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.
Soboslay PT; Dreweck CM; Hoffmann WH; Lüder CG; Heuschkel C; Görgen H; Banla M; Schulz-Key H
Clin Exp Immunol; 1992 Sep; 89(3):407-13. PubMed ID: 1516257
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune responses in human infection with Onchocerca volvulus.
Gallin M; Edmonds K; Ellner JJ; Erttmann KD; White AT; Newland HS; Taylor HR; Greene BM
J Immunol; 1988 Mar; 140(6):1999-2007. PubMed ID: 3257994
[TBL] [Abstract][Full Text] [Related]
18. Prenatal immune priming with helminth infections: parasite-specific cellular reactivity and Th1 and Th2 cytokine responses in neonates.
Pit DS; Polderman AM; Schulz-Key H; Soboslay PT
Allergy; 2000 Aug; 55(8):732-9. PubMed ID: 10955699
[TBL] [Abstract][Full Text] [Related]
19. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
